During the last session, Hims & Hers Health Inc (NYSE:HIMS)’s traded shares were 39.35 million, with the beta value of the company hitting 2.07. At the end of the trading day, the stock’s price was $51.24, reflecting an intraday gain of 4.66% or $2.28. The 52-week high for the HIMS share is $72.98, that puts it down -42.43 from that peak though still a striking 73.71% gain since the share price plummeted to a 52-week low of $13.47. The company’s market capitalization is $11.47B, and the average intraday trading volume over the past 10 days was 42.19 million shares, and the average trade volume was 45.99 million shares over the past three months.
Hims & Hers Health Inc (HIMS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.73. HIMS has a Sell rating from 0 analyst(s) out of 13 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 7 recommend a Buy rating for it.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Hims & Hers Health Inc (HIMS) registered a 4.66% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.66% in intraday trading to $51.24, hitting a weekly high. The stock’s 5-day price performance is 6.84%, and it has moved by -9.04% in 30 days. Based on these gigs, the overall price performance for the year is 111.91%. The short interest in Hims & Hers Health Inc (NYSE:HIMS) is 61.69 million shares and it means that shorts have 1.47 day(s) to cover.
The consensus price target of analysts on Wall Street is $55, which implies an increase of 6.84% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $30 and $68 respectively. As a result, HIMS is trading at a discount of -32.71% off the target high and 41.45% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.22%. While earnings are projected to return 27.49% in 2025, the next five years will return 34.58% per annum.
HIMS Dividends
Hims & Hers Health Inc is due to release its next quarterly earnings on 2025-May-05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Hims & Hers Health Inc insiders own 11.13% of total outstanding shares while institutional holders control 74.54%, with the float percentage being 83.88%. VANGUARD GROUP INC is the largest shareholder of the company, while 585.0 institutions own stock in it. As of 2024-06-30, the company held over 16.47 million shares (or 7.6746% of all shares), a total value of $332.55 million in shares.
The next largest institutional holding, with 14.57 million shares, is of BLACKROCK INC.’s that is approximately 6.7907% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $294.25 million.
Also, the Mutual Funds coming in first place with the largest holdings of Hims & Hers Health Inc (HIMS) shares are iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on May 31, 2025 indicates that iShares Trust-iShares Core S&P Mid-Cap ETF owns about 6.21 shares. This amounts to just over 2.88 percent of the company’s overall shares, with a $318.12 million market value. The same data shows that the other fund manager holds slightly less at 5.47, or about 2.54% of the stock, which is worth about $280.06 million.
